Serum levels of vascular endothelial growth factor elevated in patients with muscular dystrophy

Brain and Development

Volumn 31, Issue 8, 2009, Pages 612-617

  Saito, Toshio ^a   Yamamoto, Yuko ^a   Matsumura, Tsuyoshi ^a   Fujimura, Harutoshi ^a   Shinno, Susumu ^a  

^a TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

Becker muscular dystrophy (BMD); Duchenne muscular dystrophy (DMD); Vascular endothelial growth factor (VEGF)

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; BECKER MUSCULAR DYSTROPHY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; NEUROIMAGING; SPINAL MUSCULAR ATROPHY;

ADOLESCENT; ADULT; CREATINE KINASE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MUSCULAR ATROPHY, SPINAL; MUSCULAR DYSTROPHIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67651213696     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2008.09.008     Document Type: Article

References (31)

1. Saito T., Takenaka M., Miyai I., Yamamoto Y., Matsumura T., Nozaki S., et al. Coagulation and fibrinolysis disorder in muscular dystrophy. Muscle Nerve 24 (2001) 399-402
2. Saito T., Matsumura T., Nozaki S., and Shinno S. A case of Duchenne muscular dystrophy showing coagulation cascade activation induced by muscle destruction due to convulsion (in Japanese). Clinica Neurol 43 (2003) 274-276
3. Saito T., Yamamoto Y., Matsumura T., Nozaki S., Fujimura H., and Shinno S. Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction. Brain Dev 27 (2005) 415-418
4. Miike T., Sugino S., Ohtani Y., Taku K., and Yoshioka K. Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage. J Neurol Sci 82 (1987) 67-80
5. Sugino S., Miyatake M., Ohtani Y., Yoshioka K., Miike T., and Uchino M. Vascular alterations in Fukuyama type congenital muscular dystrophy. Brain Dev 13 (1991) 77-81
6. Klagsbrun M., and D'Amore P. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Res 7 (1996) 259-270
7. Banbury J., Siemionow M., Porvasnik S., Petras S., and Browne E. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. Plast Recontsr Surg 106 (2000) 1541-1546
8. Maeno N., Takei S., Masuda K., Akaike H., Matsuo K., Kitajima I., et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 44 (1998) 596-599
9. Slevin M., Krupinski J., Slowik A., Kumar P., Szczudlik A., and Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-β1 in serum of patients with acute ischemic stroke. Stroke 31 (2000) 1863-1870
10. Matsuyama W., Hashiguchi T., Mizoguchi A., Iwami F., Kawabata M., Arimura K., et al. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer. Chest 118 (2000) 948-951
11. Jin K.L., Mao X.O., and Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. PNAS 97 (2000) 10242-10247
12. rsk) in cultured rat cardiac myocytes. J Cell Physiol 175 (1998) 239-246
13. Germani A., Di Carlo A., Mangoni A., Straino S., Giacinti C., Turrini P., et al. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 163 (2003) 1417-1428
14. Wagatsuma A., Tamaki H., and Ogita F. Sequential expression of vascular endothelial growth factor, Flt-1, and KDR/Flk-1 in regenerating mouse skeletal muscle. Physiol Res 55 (2006) 633-640
15. Nico B., Corsi P., Vacca A., Roncali L., and Ribatti D. Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain. Brain Res 953 (2002) 12-16
16. Arahata K., Ishiura S., Ishiguro T., Tsukahara T., Suhara Y., Eguchi C., et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333 (1988) 861-863
17. Bonilla E., Samitt C.E., Miranda A.F., Hays A.P., Salviati G., DiMauro S., et al. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 54 (1988) 447-452
18. Hoffman E.P., and Wang J. Duchenne-Becker muscular dystrophy and the nondystrophic myotonias: Paradigms for loss of function and change of function of gene products. Arch Neurol 50 (1993) 1227-1237
19. Dobowitz V. Muscle disorders in childhood. 2nd ed. (1995), Saunders, London
20. Osawa M., Sumida S., Suzuki N., Arai Y., Ikenaka H., Murasugi H., et al. Fukuyama type congenital progressive muscular dystrophy. In: Fukuyama Y., Osawa M., and Saito K. (Eds). Congenital muscular dystrophy (1997), Elsevier, Amsterdam 31-68
21. Endo I., Mitsui T., Nishino M., Oshima Y., and Matsumoto T. Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome. Intern Med 41 (2002) 1196-1198
22. Koyanagi S., Kuramoto Y., Nakagawa H., Aramaki H., Ohdo S., Soeda S., et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 63 (2003) 7277-7283
23. Ishihara T. Management of patients with Duchenne muscular dystrophy (in Japanese). No to Hattatsu (Tokyo) 36 (2004) 130-135
24. Sander M., Chavoshan B., Harris S.A., Iannaccone S.T., Stull J.T., Thomas G.D., et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. PNAS 97 (2000) 13818-13823
25. Richardson R.S., Wagner H., Mudaliar S.R.D., Henry R., Noyszewski E.A., and Wagner P.D. Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol 277 (1999) 2247-2252
26. Gustafsson T., Puntschart A., Kaijser L., Jansson E., and Sundberg C.J. Exrecise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol 276 (1999) 679-685
27. Luo F., Wariaro D., Lundberg G., Blegen H., and Wahlberg E. Vascular growth factor expression in a rat model of severe limb ischemia. J Surg Res 108 (2002) 258-267
28. Olfert I.M., Breen E.C., Mathieu-Costello O., and Wagner P.D. Chronic hypoxia attenuates resting exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle. J Appl Physiol 90 (2001) 1532-1538
29. Hashimoto E., Ogita T., Nakaoka T., Matsuoka R., Takao A., and Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 267 (1994) 1948-1954
30. Frankel K.A., and Rosser R.J. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 7 (1976) 375-386
31. Goetze J.P., Gore A., Møller C.H., Steinbrüchel D.A., Rehfeld J.F., and Nielsen L.B. Acute myocardial hypoxia increases BNP gene expression. FASEB J 18 (2004) 1928-1930